https://www.iotworldtoday.com/wp-content/themes/ioti_child/assets/images/logo/IoTWorldToday-mobile-logo.png
  • Home
  • News
    • Back
    • Roundups
  • Strategy
  • Special Reports
  • Business Resources
    • Back
    • Webinars
    • White Papers
    • Industry Perspectives
    • Featured Vendors
  • Other Content
    • Back
    • Q&As
    • Case Studies
    • Features
    • How-to
    • Opinion
    • Podcasts
    • Strategic Partners
    • Latest videos
  • More
    • Back
    • About Us
    • Contact
    • Advertise
    • Editorial Submissions
  • Events
    • Back
    • IoT World Expo Austin
Iot World Today
  • NEWSLETTER
  • Home
  • News
    • Back
    • Roundups
  • Strategy
  • Special Reports
  • Business Resources
    • Back
    • Webinars
    • White Papers
    • Industry Perspectives
    • Featured Vendors
  • Other Content
    • Back
    • Q&As
    • Case Studies
    • Features
    • How-to
    • Opinion
    • Podcasts
    • Strategic Partners
    • Latest videos
  • More
    • Back
    • About Us
    • Contact
    • Advertise
    • Editorial Submissions
  • Events
    • Back
    • IoT World Expo Austin
  • newsletter
  • IIoT
  • Cities
  • Energy
  • Homes/Buildings
  • Transportation/Logistics
  • Connected Health Care
  • Retail
  • AI
  • Metaverse
  • Development
  • Security
ioti.com

Connected Health Care


FDA Clears Robotic Exoskeleton for Multiple Sclerosis Patients

Ekso Bionics’ EksoNR is the first exoskeleton device cleared for rehabilitation use for MS patients
  • Written by John Yellig
  • 5th July 2022

Ekso Bionics Holdings Inc. received approval from the U.S. Food and Drug Administration to market its EksoNR robotic exoskeleton for use with multiple sclerosis patients.

The EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use for MS patients, the company said. It was cleared for stroke and spinal-cord injury rehabilitation in 2016 and acquired brain injury (ABI) in 2020. It is also CE-marked and available in Europe.

“As a leader in early-to-market wearable robotic solutions for medical rehabilitation, we are committed to maximizing patient access to our technology,” Ekso Bionics chairman and CEO Steven Sherman said. “With the indications for use now expanded to include MS, the EksoNR has the potential to assist significantly more patients and improve patient mobility. We are excited to see the device benefit MS patients, providing critically needed rehabilitation solutions just as it has for patients suffering from stroke, spinal-cord injury and acquired brain injury.”

Unlike other exoskeletons, which are designed to be assistive devices and provide 100% of the power needed to walk, the Ekso NR is designed to be used for rehabilitation to help neurorehab patients “walk out of the device and back into their communities,” the company said.

The 60-pound suit is programmed with a suite of movements, including weight shifting, marching, stepping and tapping on a platform, split-stance and squats and provides the physical therapist visual and auditory cues to assist with care. It also has automated or therapist-programmed settings that provide varying amounts of power assistance, and all session data (walking time, distance and speed) is automatically synced to a cloud-based dashboard.

MS is a neurological autoimmune disease in which the body’s immune system attacks the central nervous system, which can disrupt communication between mind and body and lead to loss of body function and mobility. While there is no current known cure for the disease, medication management and physical therapy can help mitigate its effects. 

Physical therapy can help strengthen weakened muscles, improve range of motion and slow the progression of MS, and the EksoNR helps therapists work with patients’ brain plasticity and retrain their muscles and brains to maintain or regain lost mobility, the company said.

The suit is particularly useful for MS patients with severe symptoms because it allows therapists to program the dosage of steps patients receive, thereby reducing the threat of over-exertion, which can lead to disease advancement, Ekso said.

“MS patients who use EksoNR exoskeletons are kept apprised of their progress and must actively participate in the process to succeed,” the company said. “This direct involvement and positive progress reports can have a profound psychological effect on patients, increasing their odds of improving outcomes and regaining lost strength and mobility in addition to offering them hope.”

Tags: Ekso Bionics Holdings robotic exoskeleton EksoNR Connected Health Care News

Related Content


  • Researchers Create 3D Printing Process for Robotic Materials
    The tiny printed bots could be used to aid rescue missions or deliver targeted drugs to patients
  • AI Summit 2022: Health Care AI Group Wins Into the Den Competition
    Panakeia wins the dragon-den style pitching competition from 30 of the best and brightest AI startups
  • University of Tokyo robotic skin
    Researchers Develop Living Skin for Robots 
    Made from real human skin cells, the material has self-healing capabilities and is a major step forward for humanoid robotics
  • Vayyar Hardware Teardown
    Imaging Sensor Startup Secures $108M for 4D Imaging Pipeline
    The group had its beginnings in health care, but has expanded to retail, automotive and more

Leave a comment Cancel reply

-or-

Log in with your IoT World Today account

Alternatively, post a comment by completing the form below:

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest News

  • Pharmacy Chain Completes First Drone Prescription Delivery
  • Image shows an MRI image of brain showing area of Alzheimer patient.
    AI Model Developed to Spot Early Alzheimer’s
  • Slime Robots Created for Use in Surgery
  • Humanoid Robots Debut in Nursing Homes

Roundups

View all

IoT Product Roundup: Verizon, Microshare, SmartCow and More

15th August 2022

IoT Deals & Partnerships Roundup: Nokia, Accenture and More

29th July 2022

IoT Deals & Partnerships Roundup: Nokia, SoftBank, Microsoft and More

15th July 2022

White Papers

View all

The Role of Manufacturing Technology in Continuous Improvement Ebook

6th April 2022

IIoT Platform Trends for Manufacturing in 2022

6th April 2022

Events

View all

IoT World Expo Austin

2nd November 2022 - 3rd November 2022

Latest Videos

View all
Image shows a road within the Curiosity Lab at Peachtree Corners

Brandon Branham, Peachtree Corners, on Smart Cities

Peachtree Corners CTO and assistant city manager chats with IoT World Today’s Chuck Martin about what’s happening at Curiosity Labs

Image shows a Beep electric autonomous shuttle

Joe Moye, Beep, on Self-Driving Shuttles

Beep’s CEO chatted with IoT World Today’s Chuck Martin about the deployment of the company’s electric autonomous shuttles

E-books

View all

How Remote Access Helps Enterprises Improve IT Service and Employee Satisfaction

12th January 2022

An Integrated Approach to IoT Security

6th November 2020

Webinars

View all

Is MQTT becoming the de facto standard of Industry 4.0? The impact of IoT on industrial automation protocols

18th August 2022

Building trust for a connected world

25th August 2022

Is MQTT becoming the de facto standard of Industry 4.0? The impact of IoT on industrial automation protocols

18th August 2022

Special Reports

View all

Security: The Hidden Risks of Connected Devices

11th August 2022

Omdia’s Smart Home Market Dynamics Report

7th January 2022

Cybersecurity Protection Increasingly Depends on Machine Learning

28th October 2020

Twitter

IoTWorldToday, IoTWorldSeries

📣 Join us on August 18th to explore how MQTT has been helping system integrators to overcome the challenges of hybr… twitter.com/i/web/status/1…

16th August 2022
IoTWorldToday, IoTWorldSeries

Have you booked your free-of-charge #IoTWorld and #AISummit expo pass for Austin this November? 🤠 Don’t miss out… twitter.com/i/web/status/1…

16th August 2022
IoTWorldToday, IoTWorldSeries

Drone Developer Sold for $15.2M dlvr.it/SWjfnL https://t.co/f9HvYH9Utr

16th August 2022
IoTWorldToday, IoTWorldSeries

Walmart Taps Roaming Robots to Serve Curbside Pickup Customers dlvr.it/SWjWBP https://t.co/v0LyF0hl7z

16th August 2022
IoTWorldToday, IoTWorldSeries

Pharmacy Chain Completes First Drone Prescription Delivery dlvr.it/SWjNRq https://t.co/PpDs9cT4wf

16th August 2022
IoTWorldToday, IoTWorldSeries

🎉Listen in for an exciting SPEAKER ANNOUNCEMENT!🎉 With over 30 years+ of industry experience, Steve Brumer from B… twitter.com/i/web/status/1…

15th August 2022
IoTWorldToday, IoTWorldSeries

#HyundaiMotorGroup investing $424 million to establish the @BostonDynamics AI Institute focusing on #AI and… twitter.com/i/web/status/1…

15th August 2022
IoTWorldToday, IoTWorldSeries

IoT Product Roundup: Verizon, Microshare, SmartCow and More dlvr.it/SWfXJR https://t.co/0I14Ko86ru

15th August 2022

Newsletter

Sign up for IoT World Today newsletters: vertical industry coverage on Tuesdays and horizontal tech coverage on Thursdays.

Special Reports

Our Special Reports take an in-depth look at key topics within the IoT space. Download our latest reports.

Business Resources

Find the latest white papers and other resources from selected vendors.

Media Kit and Advertising

Want to reach our audience? Access our media kit.

DISCOVER MORE FROM INFORMA TECH

  • IoT World Series
  • Channel Futures
  • RISC-V
  • Dark Reading
  • ITPro Today
  • Web Hosting Talk

WORKING WITH US

  • Contact
  • About Us
  • Advertise
  • Login/Register

FOLLOW IoT World Today ON SOCIAL

  • Privacy
  • CCPA: “Do Not Sell My Data”
  • Cookies Policy
  • Terms
Copyright © 2022 Informa PLC. Informa PLC is registered in England and Wales with company number 8860726 whose registered and Head office is 5 Howick Place, London, SW1P 1WG.
This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our Cookie Policy and Privacy Policy.
X